MUMBAI, India, Sept. 12 -- Intellectual Property India has published a patent application (202517079803 A) filed by Janssen Pharmaceutica Nv, Beerse, Belgium, on Aug. 22, for 'gene therapy vectors for use in parkinson's disease.'
Inventor(s) include Spiller, Krista; Skariah, Geena; and Haldeman, Jonathan.
The application for the patent was published on Sept. 12, under issue no. 37/2025.
According to the abstract released by the Intellectual Property India: "Disclosed herein are recombinant gene therapy vectors comprising a PTEN-induced kinase 1 (PINK1) encoding gene that is operatively linked to a promoter and methods of using the recombinant therapy vectors for inhibiting, reducing, or delaying degeneration or death of neurons of a subj...